 AMERI Holdings, Inc. NASDAQ: AMRH Ameri, announced that its proposed amalgamation partner Jay Pharma Inc. Jay Pharma or the Company has announced the addition of new senior staff as the Company prepares to file two new investigational new drug IND applications for the treatment of radiodermatitis and glioblastoma multiforme GBM. 